Abstract
Background
Atrial fibrillation (AF) has been reported to be associated with decreased survival in population‐based studies. Its prognostic importance in end‐stage heart failure is not clear.
Methods and Results
We investigated the prognostic implications of AF as function of left ventricular (LV) ejection fraction (EF) in 8,931 consecutive patients undergoing echocardiography at our medical center between 1990 and 1999. Patient characteristics were: age 66 ± 13 years, EF 51 ± 15, AF in 1,203 patients. There were 1,911 deaths over a mean follow up of 913 days. The prevalence of AF was 11% in patients with normal left ventricular ejection fraction (LVEF) (EF ≥ 55%, n = 5, 130), and 18% each in those with mild (EF 41–54%, n = 1209), moderate (EF 26–40%, n = 1183) and severe reductions in left ventricular ejection fraction (LVEF) (EF ≤ 25%, n = 961). The 5‐year survival rate was 72% for those in sinus rhythm compared to 56% for those in AF (p < 0.0001). The effect of AF on 5‐year survival was most pronounced in those with normal LVEF (62 vs 78%, p < 0.0001) followed by those with mild reduction in LVEF (57 vs 72%, p = 0.02). It was not a predictor of survival in those with moderate (5‐year survival 55 vs 61%, p = ns) or severe LV dysfunction (5‐year survival 47 vs 45%, p = ns). Using the Cox regression model, AF was an independent predictor of mortality after correcting for age and LVEF in the entire cohort and in those with normal LVEF, but not in those with reduced LVEF. Among the other co‐morbidities analyzed, an independent effect of AF on mortality was present in those with QTc ≥ 450, raising a possibility of enhanced susceptibility of these patients.
Conclusions
The effect of AF on mortality diminishes with worsening LV function and is absent in those with severe LV dysfunction. Susceptibility of patients with QT prolongation to AF mortality warrants further attention. Copyright © 2007 Wiley Periodicals, Inc.
Keywords: atrial fibrillation, ejection fraction, mortality, echocardiogram, electrocardiogram
Full Text
The Full Text of this article is available as a PDF (250.9 KB).
References
- 1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG.: Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469–473. [PubMed] [Google Scholar]
- 2. Go AS, Hyleck EM, Phillips KA, Chang Y, Henault LE, et al.: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial fibrillation (ATRIA) Study. JAMA 2001; 285: 2370–2375. [DOI] [PubMed] [Google Scholar]
- 3. Iacovino JR: Mortality of atrial fibrillation in a population selected to be free of major cardiovascular impairments. J Insur Med 199; 31: 8–12. [PubMed] [Google Scholar]
- 4. Benjamin AJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, et al.: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946–952. [DOI] [PubMed] [Google Scholar]
- 5. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE: The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow‐Up Study. Am J Med 1995; 98: 476–484. [DOI] [PubMed] [Google Scholar]
- 6. Dries DL, Exner DV, Gersch BJ, Domanski MJ, Waclawiw MA, et al.: Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998; 32: 695–703. [DOI] [PubMed] [Google Scholar]
- 7. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, et al.: The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V‐HeFT Studies. The V‐HeFT VA Cooperative Studies Group. Circulation 1993; 87(suppl 6): VI102–VI110. [PubMed] [Google Scholar]
- 8. Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E: Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999; 83: 1544–1547. [DOI] [PubMed] [Google Scholar]
- 9. Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, et al.: Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000; 21: 1238–1245. [DOI] [PubMed] [Google Scholar]
- 10. Middlekauff HR, Stevenson WG, Stevenson LW: Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991; 84: 40–48. [DOI] [PubMed] [Google Scholar]
- 11. van Royen N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, et al.: Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996; 77: 843–850. [DOI] [PubMed] [Google Scholar]
- 12. van 't Hof AW, Schipper CW, Gerritsen JG, Reiffers S, Hoorntje JC: Comparison of radionuclide angiography with three echocardiographic parameters of left ventricular function in patients after myocardial infarction. Int J Card Imaging 1998; 14: 413–418. [DOI] [PubMed] [Google Scholar]
- 13. Amico AF, Lichtenberg GS, Reisner SA, Stone CK, Schwartz RG, et al.: Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am Heart J 1989; 118: 1259–1265. [DOI] [PubMed] [Google Scholar]
- 14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, et al.: Recommendations for quantitation of the left ventricle by two‐dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358–367. [DOI] [PubMed] [Google Scholar]
- 15. Singh SN, Poole J, Anderson J, Hellkamp AS, Karasik P, et al., SCD‐HeFT Investigators: Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am Heart J 2006; 152: 974.e7–11. [DOI] [PubMed] [Google Scholar]
- 16. Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, et al.: Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long‐term treatment with beta‐blockers: results from COMET. Eur Heart J 2005; 26: 1303–1308. [DOI] [PubMed] [Google Scholar]
- 17. Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, et al.: Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation 1998; 97: 965–970. [DOI] [PubMed] [Google Scholar]